Delivery Order SPE2DB20D3103-SPE2DB23FP1A4
Award Date 7/25/23
Potential Completion Date 7/26/23
Potential Value $1.9K
Federal Agency
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award is for the delivery of Insulin Aspart 100 Unit/ML Pen 3ML, a pharmaceutical product, to the Defense Logistics Agency (DLA). The award, valued at $8,765.68, was granted to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract has an ultimate completion date of February 1, 2024 and is a Firm Fixed Price Delivery Order. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This federal contract award is for the delivery of Insulin Aspart 100 Unit/ML Pen 3ML to the Defense Logistics Agency (DLA). The $21,528.12 firm-fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor that is a subsidiary of Cencora, Inc. The contract has an ultimate completion date of April 26, 2023 and was awarded on April 25, 2023. This delivery order is part of a larger Indefinite Delivery Contract (IDC) that Cencora, Inc. holds with the...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,845.94 firm fixed-price delivery order is for the supply of Insulin Aspart 100 Unit/mL Pen 3mL, a critical medication for diabetes management. This award is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., with the DLA Troop Support Medical, valued...
- The contract award is for the delivery of Insulin Aspart 100 Unit/mL Pen 3mL to a U.S. government agency. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor, which is a subsidiary of Cencora, Inc. The contract was awarded by the Defense Logistics Agency (DLA) and has a ceiling value of $6,381.92. The contract is a firm-fixed-price delivery order with a completion date of November 8, 2022. The contract does not have a set-aside designation, indicating open...
- This federal contract award is for the delivery of INSULIN ASPART 100 UNIT/ML PEN 3ML to support Defense Logistics Agency (DLA) healthcare programs. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for a ceiling value of $23,397.99. The award is a Delivery Order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., with the DLA Troop Support Medical. This $999,999,999 IDC serves as the primary...
- This federal contract award is for the delivery of insulin aspart 100 unit/ml pen, 3 ml, to the Defense Logistics Agency (DLA). The $4,863.40 firm fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc. The contract has a period of performance through January 11, 2024 and was not set aside for any specific small business designation. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $14,610.83 firm fixed-price delivery order is for the supply of INSULIN ASPART 100 UNIT/ML PEN 3ML medical products. The contract has an ultimate completion date of December 26, 2023. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
- This federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical is for the delivery of insulin aspart 100 unit/mL vials, a critical pharmaceutical product for the management of diabetes. The contract, valued at $5,391.27, was awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., a major pharmaceutical distribution company. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) between Cencora, Inc. and the DLA, valued at up...
- This federal contract award is for insulin aspart 100 unit/mL pens, awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $9,365.38 firm fixed-price delivery order has a completion date of May 10, 2022 and was awarded on May 9, 2022. AmerisourceBergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which operates under the "Amerisourcebergen" name. The company holds a significant $999,999,999 Indefinite...
- This federal contract award is for the delivery of Insulin Aspart 100 Unit/ML pen with a 3ML volume. The contract was awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The award has a ceiling value of $13,689.98 and is a Firm Fixed Price Delivery Order contract. No set-aside designation was used for this award. The contract is part of a larger Indefinite Delivery Contract (IDC) between Cencora, Inc. and the DLA Troop...